In vivo CRISPR screen identifies KRAS-induced COX-2 as a driver of immune evasion and immunotherapy resistance in lung cancer

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: J. Boumelha, A. de Castro, N. Bah, H. Cha, S. de Carné Trécesson, S. Rana, P. Anastasiou, E. Mugarza, C. Moore, R. Goldstone, P. East, K. Litchfield, S-H. Lee, M. Molina-Arcas, J. Downward

Journal title: Cancer Research

Journal publisher: AACR

Published year: 2024

DOI identifier: 10.1158/0008-5472.can-23-2627

ISSN: 1538-7445